GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (SHSE:603127) » Definitions » Other Current Receivables

Joinn Laboratories (China) Co (SHSE:603127) Other Current Receivables : ¥128 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Joinn Laboratories (China) Co Other Current Receivables?

Joinn Laboratories (China) Co's Other Current Receivables for the quarter that ended in Sep. 2024 was ¥128 Mil.

Joinn Laboratories (China) Co's quarterly Other Current Receivables increased from Mar. 2024 (¥123.17 Mil) to Jun. 2024 (¥129.66 Mil) but then stayed the same from Jun. 2024 (¥129.66 Mil) to Sep. 2024 (¥128.06 Mil).

Joinn Laboratories (China) Co's annual Other Current Receivables increased from Dec. 2021 (¥112.73 Mil) to Dec. 2022 (¥148.26 Mil) but then declined from Dec. 2022 (¥148.26 Mil) to Dec. 2023 (¥145.55 Mil).


Joinn Laboratories (China) Co Other Current Receivables Historical Data

The historical data trend for Joinn Laboratories (China) Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co Other Current Receivables Chart

Joinn Laboratories (China) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 75.54 77.75 112.73 148.26 145.55

Joinn Laboratories (China) Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.67 145.55 123.17 129.66 128.06

Joinn Laboratories (China) Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Joinn Laboratories (China) Co Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Joinn Laboratories (China) Co Business Description

Traded in Other Exchanges
Address
A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Executives
Yao Da Lin Director
Sun Yun Xia Director
Zuo Cong Lin Director
Gao Da Peng Director
Li Ye Supervisors
Gu Xiao Lei Director
Feng Yu Xia Director
Gu Jing Liang senior management
Yu Ai Shui senior management
Yin Li Li Supervisors
Sun Hui Ye Supervisors
Gu Mei Fang Director

Joinn Laboratories (China) Co Headlines

No Headlines